Replies to post #129723 on Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

How much revenue has MANF produced?

It was the reason why I took a stake in AMBS is 2012, however MANF is an untapped protein.

While it achieved ODD, it was targeted for 1st in-man clinical studies in 2016 under Catalent Pharma who was hired to perform cGMP for clinical-grade production of MANF, but no progress was ever made.

Its been around for decades, but has yet to make it out of preclinicals:

https://www.researchgate.net/project/Discovery-of-MANF

It sits in pre-clinicals 'proof of concept' for RP, RAO, AMD, DB, PK and MYO-CDI.

If it truly holds the possibility of being a genuine game changer, then why hasn't Gerald advanced it forward given unlimited time and opportunities to do so?